Deep search
All
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Search
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Merck Halts Gardasil Sales in China
Merck's 2025 revenue outlook falls short as it pauses Gardasil vaccine shipments to China
Merck's full-year 2025 revenue guidance fell short of what some analysts were expecting, at a range of $64.1 billion to $65.6 billion.
Merck pauses Gardasil shipments to China, hitting its 2025 outlook
Merck said it will pause shipments of Gardasil to China through at least mid-year, as continued weak demand for the HPV vaccine there is expected to hurt 2025 revenue, but it still posted a strong fourth-quarter profit on sales of cancer drug Keytruda.
Merck Halts Gardasil Sales in China, Dragging on 2025 Outlook
Merck & Co. is halting shipments to China of its cancer-preventing Gardasil vaccine, threatening the future of one of its best-selling products and dragging down the company’s outlook in the process.
20m
Merck Announces Fourth-Quarter and Full-Year 2024 Financial Results
RAHWAY, N.J., February 04, 2025 -- ( BUSINESS WIRE )--Merck (NYSE: MRK), known as MSD outside the United States and Canada, ...
9m
Merck 4Q Sales Increase Results in Swing to Profit
Merck swung to a fourth-quarter profit as sales grew and even exceeded Wall Street's estimates, boosted in part by the performance of top asset Keytruda. The drug company logged net income of $3.74 ...
18h
Merck Vs. Pfizer: Which Pharmaceutical Giant Will Prevail In Q4 Earnings?
Merck and Pfizer are heading into fourth quarter earnings with different technical setups, leaving investors unsure of which ...
5d
Merck to stop lung condition drug study early due to strong efficacy data
Merck plans to stop a late-stage study testing its drug to treat pulmonary arterial hypertension (PAH) ahead of time based on ...
1d
Merck’s Winrevair: A Catalyst for Stock Growth Amid Promising Clinical Developments
In a report released on January 30, Daina Graybosch from Leerink Partners maintained a Buy rating on Merck & Company (MRK – Research ...
4d
Merck, Black Ex-Director Headed for Discriminatory Firing Trial
Merck must face trial on a Black IT director’s claims that racial bias drove his firing after he ordered the removal of a ...
11d
Merck and Eisai's cancer drugs fail to improve overall survival in late-stage trial
Merck's blockbuster drug Keytruda and Eisai's cancer drug Lenvima, in combination with chemotherapy, failed to improve ...
4d
Merck & Company Hold Rating: Promising Drug Developments Amid Uncertain Financial Outlook
Morgan Stanley analyst Terence Flynn has maintained their neutral stance on MRK stock, giving a Hold rating yesterday.Invest with Confidence: ...
Zawya
20h
Merck Foundation and First Ladies of Africa mark World Cancer Day 2025: 194 Oncology Scholarships Provided Across 32 African Countries
Merck Foundation and First Ladies of Africa mark World Cancer Day 2025: 194 Oncology Scholarships Provided Across 32 African ...
15h
on MSN
Gardasil Worries Loom as Merck Reports Earnings
Merck shares are down more than 20% over the past 12 months after trouble with sales of its Gardasil vaccine in China ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Related topics
Gardasil vaccine
Robert F. Kennedy Jr.
European Union
S&P 500 Index
World Cancer Day
Feedback